DelmarvaNow

Chitosan-based Hemostasis Management Products Market to Double to $3.20B by 2033 – Strategic Revenue Insights (SRI)

Market valued at $1.45B in 2024 grows at 10.4% CAGR driven by biocompatible hemostatic solutions in surgical and trauma care settings. The shift toward nature-derived hemostatic solutions reflects ...
Yahoo Finance

Preclinical Evaluation of Tricol Biomedical’s Absorbable Biocompatible Chitosan (ABC) Wound Dressing Demonstrates Bioabsorption and Biocompatability in Internal Bleeding

Portland, OR, Sept. 29, 2022 (GLOBE NEWSWIRE) -- A preclinical study presented at the Military Health System Research Symposium (MHSRS) this month demonstrated that the proprietary † Absorbable ...
The News Leader

Chitosan-based Hemostasis Management Products Market to Double to $3.20B by 2033 – Strategic Revenue Insights (SRI)

These products can absorb significant volumes of blood while releasing chitosan particles that activate coagulation cascades. The powder segment represents the fastest-growing category, fueled by ...
Taunton Daily Gazette

Chitosan-based Hemostasis Management Products Market to Double to $3.20B by 2033 – Strategic Revenue Insights (SRI)

The doubling of market valuation from $1.45 billion to $3.20 billion by 2033 represents more than numerical growth; it signals a fundamental evolution in surgical and emergency medicine practices. The ...